http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8987429-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a369d035961cf7b99a9747eb64835014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a13ef4e9c47c98187150acbf362841d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ade351f776309e1fc0beb37821ea0a94
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10
filingDate 2012-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_770c13ea81f3354dc3832bb2085f7381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6d3cda6f49bc2d8c94874fb5db34f83
publicationDate 2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8987429-B2
titleOfInvention GO-Gd-DTPA complex, preparation method thereof, and MRI contrast agent comprising the same
abstract Disclosed herein is a GO-Gd-DTPA (gadolinium-diethylenetriamine pentaacetic-graphene oxide) complex, which is formed by an ester bond of graphene oxide (GO) and gadopentetic acid (Gd-DTPA). Since the GO-Gd-DTPA can stably exist in the body because it has high stability in water, it is expected that it can be effectively used as an MRI contrast agent.
priorityDate 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012058054-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86734857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57459998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452538690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449851370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449859524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128961115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450540594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13001166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452386624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412224690

Total number of triples: 52.